Immunogenicity, the elephant in the room. Comment on "Drug levels, anti-drug antibodies and clinical efficacy of the anti-TNFα biologics in rheumatic diseases"

被引：2
|
作者：
Pixley, John [1 ,2 ]
机构：
[1] Univ Nevada, Sch Med, Div Rheumatol, Reno, NV 89557 USA
[2] Univ VA Sierra Heath Care Syst, Div Immunol, Reno, NV USA
来源：
CLINICAL RHEUMATOLOGY | 2013年 / 32卷 / 10期
关键词：
ABATACEPT; ARTHRITIS;
D O I：
10.1007/s10067-013-2364-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1413 / 1413
页数：1
相关论文
共 50 条
  • [41] REVERSAL OF ANTI-DRUG ANTIBODIES TO ANTI-TNF THERAPY WITH ADDITION OF IMMUNOMODULATORS: A SYSTEMIC REVIEW AND META-ANALYSIS
    Kucharski, Kimberly
    Kashani, Amir
    GASTROENTEROLOGY, 2023, 164 (06) : S655 - S655
  • [42] Comparison of Homogeneous Mobility Shift Assay and Solid Phase ELISA for the Measurement of Drug and Anti-Drug Antibody (ADA) Levels in Serum From Patients Treated With Anti-TNF Biologics
    Hauenstein, Scott
    Ohrmund, Linda
    Salbato, Jared
    Reddy, Rukmini
    McCowen, Kevin
    Monk, Patrick
    Lockton, Steven
    Wang, Shui-Long
    Singh, Sharat
    GASTROENTEROLOGY, 2012, 142 (05) : S538 - S538
  • [43] Clinical Utility of Random Anti-TNF Drug Level Testing and Measurement of Anti-Drug Antibodies on Long-Term Treatment Response in Rheumatoid Arthritis.
    Jani, Meghna
    Chinoy, Hector
    Warren, Richard B.
    Griffiths, Christopher E. M.
    Morgan, Ann W.
    Wilson, Anthony G.
    Hyrich, Kimme L.
    Isaacs, John
    Plant, Darren
    Barton, Anne
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1278 - S1278
  • [44] INCREASED FREQUENCY OF ANTI-DRUG ANTIBODIES IN PATIENTS CARRYING COMPATIBLE IGG1 ALLOTYPES AND TREATED WITH ANTI-TNF ANTIBODIES
    Lopez-Rodriguez, R.
    Martinez, A.
    Plasencia, C.
    Jochems, A.
    Pascual-Salcedo, D.
    Balsa, A.
    Gonzalez, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 59 - 59
  • [45] Increased Frequency of Anti-Drug Antibodies in Patients Carrying Compatible IgG1 Allotypes and Treated with Anti-TNF Antibodies
    Gonzalez, Antonio
    Lopez-Rodriguez, Rosario
    Martinez, Ana
    Plasencia-Rodriguez, Chamaida
    Jochems, Andrea
    Pascual-Salcedo, Dora
    Balsa, Alejandro
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [46] Anti-tumor necrosis factor drug therapy: The usefulness of monitoring drug levels and anti-drug antibodies in clinical practice
    Garcia Ruiz de Morales, Jose M.
    Pascual-Salcedo, Dora
    Llinares Tello, Francisca
    Valor Mendez, Larissa
    MEDICINA CLINICA, 2016, 147 (09): : 410 - 416
  • [47] THE PRESENCE OF ANTI-NUCLEAR ANTIBODIES BEFORE ANTI-TNF THERAPY IS A RISK FACTOR FOR THE APPEARANCE OF ANTI-DRUG ANTIBODIES IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Kumagai, Shunichi
    Mori, Ayano
    Saito, Toshiharu
    Takahashi, Miho
    Yoneda, Katsuhiko
    Noda, Yasuhiro
    Takahashi, Soushi
    Nishida, Miwa
    Hatachi, Saori
    Tsuji, Goh
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1149 - 1150
  • [48] IN SPONDYLOARTHRITIS; DOES IMMUNOGENICITY INFLUENCE ON DRUG SURVIVAL OF ANTI-TNF?
    Garcia-Carazo, S.
    Plasencia, C.
    Pascual-Salcedo, D.
    Peiteado, D.
    Bonilla, G.
    Nuno, L.
    Villalba, A.
    Diaz, M.
    Arribas, F.
    Balsa, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 820 - 820
  • [49] Anti-Drug Antibodies Are Associated with Diminished Drug Levels and Treatment Failure
    Kosmac, Miha
    Toplak, Natasa
    Simonini, Gabriele
    Pagnini, Ilaria
    Cimaz, Rolando
    Serbec, Vladka Curin
    Avcin, Tadej
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1099 - S1100
  • [50] SERUM LEVELS OF THE ANTI-TNF BIOLOGICS CORRELATE WITH CLINICAL EFFICACY IN PATIENTS WITH INFLAMMATORY ARTHRITIS
    Mok, C. C.
    Fong, B.
    Ho, L. Y.
    To, C. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 825 - 825
12345